Tikcro

Unique Antibody Generation Approach for Cancer Immunotherapy: Using 3D antigen immunization technology, we aim to increase the therapeutic window ‎and the blocking functionality of antibodies for cancer treatment. This technology enables ‎the development of new therapeutic antibodies for immuno-oncology that address key ‎limitations of existing antibody drugs and methodologies. Several antibodies for cancer immunotherapy have recently resulted in meaningful ‎improvements and clinical efficacy in treating cancer. In addition, a certain ‎portion of patients stop the treatment due to toxicity, as such antibodies trigger immune-‎related adverse events. These toxicities limit the therapeutic benefit of the treatment.